Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma.
暂无分享,去创建一个
Bin Zhang | L. Bie | X. Wan | Q. Fu | S. Luo | Ning Li | W. Deng | Zhi Li | Chen Wei | Mengyu Wang | Yijie Ma | Chao-min Lu | Jinbang Wang | Jian Zhang